Literature DB >> 27061505

Plasma levels of vitamin K and the risk of ischemic heart disease: a Mendelian randomization study.

C M Schooling1.   

Abstract

UNLABELLED: Essentials Vitamin K plays a role in coagulation, and deficiency may promote coronary artery calcification. The role of vitamin K1 in heart disease was assessed using Mendelian randomization in Caucasians. Genetically higher vitamin K1 was associated with a higher risk of ischemic heart disease. Further research elucidating the role of vitamin K1 in ischemic heart disease could be useful.
SUMMARY: Background Vitamin K1 is a nutrient in green leafy vegetables; deficiency may promote coronary artery calcification. Warfarin, an anticoagulant used in secondary prevention of thrombotic events, is a vitamin K antagonist. Thrombotic and coronary events may share risk factors. Objectives To clarify the role of vitamin K1 in ischemic heart disease, the risk of coronary artery disease/myocardial infarction (CAD/MI) was assessed according to genetically determined vitamin K1 levels. Given vitamin K1 is fat soluble, associations with lipids were similarly assessed to assess pleotropic effects via lipids. Methods Separate sample instrumental variable analysis with genetic instruments (Mendelian randomization) was used to obtain an unconfounded estimate of the association of vitamin K1 (based on rs2108622 [CYP4F2], rs4645543 [KCNK9] and rs2192574 [CTNNA2] from a genome-wide association study) with CAD/MI using CARDIoGRAMplusC4D (cases = 64 374; controls = 130 681) and with lipids using Global Lipids Genetics Consortium Results (n = 196 475). Results Vitamin K1 single nucleotide polymorphisms were positively associated with CAD/MI (odds ratio [OR], 1.17 per unit [nmol L(-1) ] of natural log-transformed genetically predicted vitamin K1 ; 95% confidence interval [CI], 1.08-1.26), but not with inverse normal transformed low-density lipoprotein cholesterol (-0.0003; 95% CI, -0.03 to 0.03), high-density lipoprotein cholesterol (0.02; 95% CI, -0.01 to 0.05) or triglycerides (-0.01; 95% CI, -0.04 to 0.02). Considering only rs2108622, which is functionally relevant to vitamin K1 , the association for CAD/MI was stronger (OR, 1.21; 95% CI, 1.08-1.36). Conclusions Vitamin K may cause CAD/MI; whether vitamin K or other determinants of coagulation could be relevant to primary prevention might be worth considering.
© 2016 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  Mendelian randomization analysis; heart diseases; lipids; vitamin K; warfarin

Mesh:

Substances:

Year:  2016        PMID: 27061505     DOI: 10.1111/jth.13332

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

1.  Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments.

Authors:  C M Schooling; J V Huang; J V Zhao; M K Kwok; S L Au Yeung; S L Lin
Journal:  EBioMedicine       Date:  2018-01-31       Impact factor: 8.143

2.  Genomic Tools for the Conservation and Genetic Improvement of a Highly Fragmented Breed-The Ramo Grande Cattle from the Azores.

Authors:  Andreia J Amaral; Ana L Pavão; Luis T Gama
Journal:  Animals (Basel)       Date:  2020-06-24       Impact factor: 2.752

3.  Heritability and Genome-Wide Association Study of Plasma Cholesterol in Chinese Adult Twins.

Authors:  Hui Liu; Weijing Wang; Caixia Zhang; Chunsheng Xu; Haiping Duan; Xiaocao Tian; Dongfeng Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-15       Impact factor: 5.555

4.  Circulating phylloquinone, inactive Matrix Gla protein and coronary heart disease risk: A two-sample Mendelian Randomization study.

Authors:  Sabine R Zwakenberg; Stephen Burgess; Ivonne Sluijs; Elisabete Weiderpass; Joline W J Beulens; Yvonne T van der Schouw
Journal:  Clin Nutr       Date:  2019-05-07       Impact factor: 7.643

5.  Circulating Vitamin K₁ Levels in Relation to Ischemic Stroke and Its Subtypes: A Mendelian Randomization Study.

Authors:  Susanna C Larsson; Matthew Traylor; Hugh S Markus
Journal:  Nutrients       Date:  2018-10-25       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.